JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
AQST Financials - Aquestive Therapeutics Income & Cash Flow | Ledgeburg
AQST - Aquestive Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary AQST Stock
Financials
Financials AQST Stock
Loading...
Loading...
Income Statement
Income Statement AQST Stock
Balance Sheet
Balance Sheet AQST Stock
Cash Flow Statement
Cash Flow Statement AQST Stock
Loading...
Loading...
Home
Stocks
Aquestive Therapeutics, Inc. (AQST)
Financials
Financials of AQST
Loading...
Loading...
Loading...
Loading...
Revenue
$44.545M
Operating Income
$-71.051M
Net Income
$-83.784M
Share Count (Basic)
106.926528M
Operating Cash Flow
$-52.432M
Free Cash Flow
$-52.994M
Cash And Short-Term Equivalents
N/A
Total Debt
$45M
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
5M
10M
15M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-80M
-60M
-40M
-20M
0
Annual
Quarterly
Margins
Gross
Operating
Net
-200%
-150%
-100%
-50%
0%
50%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-30M
-25M
-20M
-15M
-10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-300%
-200%
-100%
0%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26